• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维性骨发育不良进展性的影像学评估:定性、定量和可疑。

Imaging assessment of fibrodysplasia ossificans progressiva: Qualitative, quantitative and questionable.

机构信息

Department of Medicine, The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, United States; The Center for Research in FOP and Related Disorders, The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, United States.

Department of Radiology, The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, United States; Department of Orthopedics, The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, United States.

出版信息

Bone. 2018 Apr;109:147-152. doi: 10.1016/j.bone.2017.08.011. Epub 2017 Aug 16.

DOI:10.1016/j.bone.2017.08.011
PMID:28822792
Abstract

Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare autosomal dominant genetic disorder of heterotopic ossification (HO) characterized by skeletal anomalies and episodic soft tissue swelling (flare-ups) that can transform into heterotopic bone. The progressive development of heterotopic bone and progressive arthropathy leads to significant limitation of mobility. This paper will review various imaging modalities used in evaluating episodic soft tissue swelling (flare-ups), heterotopic bone and skeletal anomalies. Different imaging modalities are required at different stages of the disease. Ultrasound and MRI can be useful for evaluating edema in early stages of a flare-up; MRI being superior to ultrasonography. Plain radiographs and computed tomography (CT) can evaluate heterotopic bone in later stages of HO, but CT scan is better at evaluating presence and the volume of heterotopic bone. Functional imaging demonstrates increased activity at sites of flare-ups, their utility in determining disease progression need to be further evaluated. Cost, radiation exposure, availability of various imaging modalities and the ability of FOP patients to fit in the scanner are all considerations when requesting radiographic tests in a patient with FOP. Future studies are required to determine if early radiographic findings can determine disease progression and response to treatment in this disorder.

摘要

进行性骨化性纤维发育不良(FOP)是一种罕见的常染色体显性遗传的异位骨化(HO)疾病,其特征为骨骼异常和偶发性软组织肿胀(发作),可转化为异位骨。异位骨的进行性发展和进行性关节病导致运动能力显著受限。本文将回顾用于评估偶发性软组织肿胀(发作)、异位骨和骨骼异常的各种影像学检查方法。不同的影像学检查方法在疾病的不同阶段都有需要。超声和 MRI 可用于评估发作早期的水肿;MRI 优于超声。平片和计算机断层扫描(CT)可评估 HO 后期的异位骨,但 CT 扫描更能评估异位骨的存在和体积。功能成像显示发作部位的活性增加,但其在确定疾病进展方面的效用需要进一步评估。在 FOP 患者中请求放射学检查时,需要考虑成本、辐射暴露、各种影像学检查方法的可用性以及 FOP 患者是否能适应扫描仪。未来的研究需要确定早期放射学发现是否可以确定该疾病的进展和对治疗的反应。

相似文献

1
Imaging assessment of fibrodysplasia ossificans progressiva: Qualitative, quantitative and questionable.纤维性骨发育不良进展性的影像学评估:定性、定量和可疑。
Bone. 2018 Apr;109:147-152. doi: 10.1016/j.bone.2017.08.011. Epub 2017 Aug 16.
2
Characterization of flare-ups and impact of garetosmab in adults with fibrodysplasia ossificans progressiva: a post hoc analysis of the randomized, double-blind, placebo-controlled LUMINA-1 trial.成纤维细胞性骨化发育不良成人患者flare-ups 的特征及 garetosmab 的影响:LUMINA-1 试验的一项随机、双盲、安慰剂对照的事后分析。
J Bone Miner Res. 2024 Sep 26;39(10):1486-1492. doi: 10.1093/jbmr/zjae140.
3
[18F]NaF PET/CT scan as an early marker of heterotopic ossification in fibrodysplasia ossificans progressiva.[18F]NaF PET/CT 扫描作为进行性骨化性纤维发育不良中异位骨化的早期标志物。
Bone. 2018 Apr;109:143-146. doi: 10.1016/j.bone.2017.08.012. Epub 2017 Aug 18.
4
The Expansion of Heterotopic Bone in Fibrodysplasia Ossificans Progressiva Is Activin A-Dependent.纤维性骨发育不良性骨生成过度中的异位骨形成是激活素 A 依赖性的。
J Bone Miner Res. 2017 Dec;32(12):2489-2499. doi: 10.1002/jbmr.3235. Epub 2017 Sep 22.
5
The obligatory role of Activin A in the formation of heterotopic bone in Fibrodysplasia Ossificans Progressiva.在进行性骨化性纤维发育不良中,激活素 A 在异位骨形成中的必然作用。
Bone. 2018 Apr;109:210-217. doi: 10.1016/j.bone.2017.06.011. Epub 2017 Jun 16.
6
Analog Method for Radiographic Assessment of Heterotopic Bone in Fibrodysplasia Ossificans Progressiva.进行性骨化性纤维发育不良中异位骨的X线评估模拟方法
Acad Radiol. 2017 Mar;24(3):321-327. doi: 10.1016/j.acra.2016.10.010. Epub 2016 Dec 15.
7
Depletion of Mast Cells and Macrophages Impairs Heterotopic Ossification in an Acvr1 Mouse Model of Fibrodysplasia Ossificans Progressiva.破骨细胞和巨噬细胞耗竭可损害 Acvr1 小鼠纤维性骨发育不良进展性异位骨化模型中的异位骨化。
J Bone Miner Res. 2018 Feb;33(2):269-282. doi: 10.1002/jbmr.3304. Epub 2018 Jan 3.
8
Skeletal malformations and developmental arthropathy in individuals who have fibrodysplasia ossificans progressiva.纤维性骨发育不良所致骨化性肌炎患者的骨骼畸形和发育性关节病。
Bone. 2020 Jan;130:115116. doi: 10.1016/j.bone.2019.115116. Epub 2019 Oct 23.
9
Longitudinal patient-reported mobility assessment in fibrodysplasia ossificans progressiva (FOP).进行性骨化性纤维发育不良(FOP)患者的纵向报告移动性评估。
Bone. 2018 Apr;109:158-161. doi: 10.1016/j.bone.2017.06.005. Epub 2017 Jun 6.
10
Fibrodysplasia Ossificans Progressiva进行性骨化性纤维发育不良

引用本文的文献

1
[F]NaF PET/CT as a Marker for Fibrodysplasia Ossificans Progressiva: From Molecular Mechanisms to Clinical Applications in Bone Disorders.氟[18F]去铁胺 PET/CT 作为成骨不全性骨纤维发育异常的标志物:从分子机制到骨骼疾病的临床应用。
Biomolecules. 2024 Oct 10;14(10):1276. doi: 10.3390/biom14101276.
2
The terminal period findings of late-diagnosed fibrodysplasia ossificans progressiva.晚期诊断的进行性骨化性纤维发育不良的终末期发现。
Ger Med Sci. 2023 Jul 11;21:Doc12. doi: 10.3205/000326. eCollection 2023.
3
The Efficacy of CT Temporal Subtraction Images for Fibrodysplasia Ossificans Progressiva.
CT 时间减影图像在纤维性骨发育不良中的疗效。
Tomography. 2023 Apr 3;9(2):768-775. doi: 10.3390/tomography9020062.
4
Diminished muscle integrity in patients with fibrodysplasia ossificans progressiva assessed with at-home electrical impedance myography.应用家庭式电阻抗肌图评估进行性骨化性纤维发育不良患者的肌肉完整性受损。
Sci Rep. 2022 Dec 3;12(1):20908. doi: 10.1038/s41598-022-25610-7.
5
Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop.骨化性纤维发育不良进展性:我们已经取得了哪些成就,现在又在哪里?对 2015 年洛伦茨研讨会的跟进。
Front Endocrinol (Lausanne). 2021 Nov 10;12:732728. doi: 10.3389/fendo.2021.732728. eCollection 2021.
6
Fibrodysplasia ossificans progressiva: Diagnosis with ultrasound.进行性骨化性纤维发育不良:超声诊断
Australas J Ultrasound Med. 2021 May 5;24(3):173-177. doi: 10.1002/ajum.12245. eCollection 2021 Aug.
7
Whole-body Computed Tomography Versus Dual Energy X‑ray Absorptiometry for Assessing Heterotopic Ossification in Fibrodysplasia Ossificans Progressiva.全身计算机断层扫描与双能 X 射线吸收法在纤维发育不良性骨化性纤维瘤中评估异位骨化的比较。
Calcif Tissue Int. 2021 Dec;109(6):615-625. doi: 10.1007/s00223-021-00877-6. Epub 2021 Jul 31.
8
F-Sodium Fluoride PET as a Diagnostic Modality for Metabolic, Autoimmune, and Osteogenic Bone Disorders: Cellular Mechanisms and Clinical Applications.F-氟化钠 PET 作为代谢性、自身免疫性和骨原性骨疾病的诊断手段:细胞机制和临床应用。
Int J Mol Sci. 2021 Jun 17;22(12):6504. doi: 10.3390/ijms22126504.
9
Compartment Syndrome of the Thigh in a Patient with Fibrodysplasia Ossificans Progressiva.进行性骨化性纤维发育不良患者的大腿骨筋膜室综合征
J Orthop Case Rep. 2020 May-Jun;10(3):103-107. doi: 10.13107/jocr.2020.v10.i03.1770.
10
Cardiopulmonary and Neurologic Dysfunctions in Fibrodysplasia Ossificans Progressiva.进行性骨化性纤维发育不良中的心肺和神经功能障碍
Biomedicines. 2021 Feb 5;9(2):155. doi: 10.3390/biomedicines9020155.